Detalhe da pesquisa
1.
Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
Viruses
; 14(9)2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146735
2.
Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.
Sci Rep
; 12(1): 21053, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473907
3.
A review of the main histopathological findings in coronavirus disease 2019.
Hum Pathol
; 105: 74-83, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32750378